| scholarly article | Q13442814 |
| P2093 | author name string | Marcel M Verbeek | |
| Irene Otte-Höller | |||
| Judianne Davis | |||
| William E Van Nostrand | |||
| Micha M M Wilhelmus | |||
| Robert M W de Waal | |||
| P2860 | cites work | High frequency of apolipoprotein E ?2 Allele in hemorrhage due to cerebral amyloid angiopathy | Q59691932 |
| Apolipoprotein E genotyping by one-stage PCR | Q68299031 | ||
| Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI | Q68789670 | ||
| T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions | Q71693370 | ||
| Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease | Q72391030 | ||
| Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease | Q73789480 | ||
| Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy | Q74496715 | ||
| Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease | Q24682442 | ||
| Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease | Q28238269 | ||
| Isoform-specific binding of apolipoprotein E to beta-amyloid | Q28596589 | ||
| The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 | ||
| Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 | ||
| Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease. | Q31949934 | ||
| Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line | Q33848287 | ||
| Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier | Q33928434 | ||
| Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3 | Q34229659 | ||
| Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system | Q34559847 | ||
| Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease | Q34662682 | ||
| Specific regional transcription of apolipoprotein E in human brain neurons | Q35745315 | ||
| Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease | Q35774045 | ||
| Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro | Q35834037 | ||
| Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease | Q36604545 | ||
| Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid | Q36707976 | ||
| Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease | Q36784564 | ||
| Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein | Q37683153 | ||
| LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. | Q40528558 | ||
| Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease | Q40849918 | ||
| A test of the cytosolic apolipoprotein E hypothesis fails to detect the escape of apolipoprotein E from the endocytic pathway into the cytosol and shows that direct expression of apolipoprotein E in the cytosol is cytotoxic. | Q40965861 | ||
| A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins | Q41056322 | ||
| Thrombin receptor activation induces secretion and nonamyloidogenic processing of amyloid beta-protein precursor | Q41442753 | ||
| Accumulation of the amyloid-beta precursor protein in multivesicular body-like organelles. | Q41917662 | ||
| Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy | Q41927992 | ||
| Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. | Q42754593 | ||
| Inhibition of amyloid-beta-induced cell death in human brain pericytes in vitro | Q44167757 | ||
| Insulin inhibits amyloid beta-induced cell death in cultured human brain pericytes | Q44693513 | ||
| Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy | Q44822600 | ||
| Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells | Q46096613 | ||
| Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides | Q47349499 | ||
| Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations | Q48248632 | ||
| Human brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer's disease. | Q48250504 | ||
| Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. | Q48477194 | ||
| Nascent astrocyte particles differ from lipoproteins in CSF. | Q48478094 | ||
| Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease | Q48633197 | ||
| Rapid degeneration of cultured human brain pericytes by amyloid beta protein. | Q48793512 | ||
| Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease | Q49171338 | ||
| Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. | Q53224959 | ||
| Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. | Q53310511 | ||
| Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. | Q53350049 | ||
| Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments | Q59053832 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytotoxicity | Q246181 |
| P304 | page(s) | 3621-3627 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Apolipoprotein E genotype regulates amyloid-beta cytotoxicity | |
| P478 | volume | 25 |
| Q35662397 | Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway |
| Q35474565 | Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis |
| Q39257249 | Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease |
| Q52606699 | Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury. |
| Q57023036 | Blood-Brain Barrier: From Physiology to Disease and Back |
| Q57810850 | Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism |
| Q36961152 | Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease |
| Q37133530 | Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice |
| Q42044152 | Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: a potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease |
| Q36202900 | Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells |
| Q36448521 | Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models |
| Q36330352 | Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress |
| Q26740342 | Role of ROS and RNS Sources in Physiological and Pathological Conditions |
| Q41076513 | The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy |
| Q48326078 | The pathogenesis of Alzheimer's disease and the role of Abeta42. |
| Q36813704 | The role of APOE in cerebrovascular dysfunction |
| Q40822165 | Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity |
| Q43243545 | apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain |
Search more.